慢性骨髓增殖性肿瘤患者血小板纤维蛋白原受体表达意外降低及阿司匹林的影响
研究纳入40例费城染色体阴性慢性骨髓增殖性肿瘤(MPN)患者及健康志愿者,用流式细胞术检测血小板P-选择素、整合素β-3、GPIIb/IIIa活化及纤维蛋白原受体暴露(PAC-1结合)。发现MPN患者PAC-1结合能力非常低,但阿司匹林摄入后几乎完全恢复;提示MPN高凝状态可能主要源于血浆驱动的纤维蛋白周转和凝血酶生成障碍。
要点
- MPN患者血小板PAC-1结合能力意外降低。
- 阿司匹林摄入后PAC-1表达几乎完全恢复。
- 高凝状态可能主要与血浆驱动因素相关。
核心结论
- MPN患者血小板纤维蛋白原受体(PAC-1结合)表达非常低,但阿司匹林摄入后几乎完全恢复。
研究设计与样本
- 研究收集40例连续MPN患者及健康志愿者的血样,采用流式细胞术分析血小板P-选择素、整合素β-3、GPIIb/IIIa活化及PAC-1结合。
主要发现
- MPN患者血小板PAC-1结合能力非常低。
- 阿司匹林摄入后PAC-1表达几乎完全恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study was conducted to evaluate the expression of fibrinogen receptors on platelets of Philadelphia-negative chronic myeloproliferative neoplasm (MPN) patients. We collected blood samples from 40 consecutive MPN patients and healthy volunteers. We performed flow cytometry analysis of P-selectin expression and integrin beta-3, activation of glycoprotein (GP) IIb/IIIa and fibrinogen receptor exposure (PAC-1 binding). Surprisingly, we found a very low PAC-1 binding capacity in MPN patients; however, the expression of PAC-1 was almost completely recovered with aspirin intake. We hypothesize that the hypercoagulable states observed in MPN patients could depend on a primarily plasma-driven impairment of fibrin turnover and thrombin generation.
引用
- Lucchesi A, Carloni S, De Matteis S, et al. Unexpected low expression of platelet fibrinogen receptor in patients with chronic myeloproliferative neoplasms: how does it change with aspirin? Br J Haematol. 2019. PMID: 31792942. doi:10.1111/bjh.16335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。